Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.

Brunner AM, Blonquist TM, DeAngelo DJ, McMasters M, Fell G, Hermance NM, Winer ES, Lindsley RC, Hobbs GS, Amrein PC, Hock HR, Steensma DP, Garcia JS, Luskin MR, Stone RM, Ballen KK, Rosenblatt J, Avigan D, Nahas MR, Mendez LM, McAfee SL, Moran JA, Bergeron M, Foster J, Bertoli C, Manning AL, McGregor KL, Fishman KM, Kuo FC, Baltay MT, Macrae M, Burke M, Behnan T, Wey MC, Som TT, Ramos AY, Rae J, Lombardi Story J, Nelson N, Logan E, Connolly C, Neuberg DS, Chen YB, Graubert TA, Fathi AT.

Lancet Haematol. 2019 Dec 11. pii: S2352-3026(19)30203-0. doi: 10.1016/S2352-3026(19)30203-0. [Epub ahead of print]

PMID:
31837959
2.

Colonic Wall Thickening as the First Indicator of Relapse of Acute Lymphoblastic Leukemia.

Hathorn KE, Luskin MR, Caton MT Jr, DeAngelo DJ, Saltzman JR.

ACG Case Rep J. 2019 Sep 2;6(8):e00207. doi: 10.14309/crj.0000000000000207. eCollection 2019 Aug.

3.

Homogenization of plasmonic crystals: seeking the epsilon-near-zero effect.

Maier M, Mattheakis M, Kaxiras E, Luskin M, Margetis D.

Proc Math Phys Eng Sci. 2019 Oct;475(2230):20190220. doi: 10.1098/rspa.2019.0220. Epub 2019 Oct 9.

PMID:
31736641
4.

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.

Zhang H, Wilmot B, Bottomly D, Dao KT, Stevens E, Eide CA, Khanna V, Rofelty A, Savage S, Reister Schultz A, Long N, White L, Carlos A, Henson R, Lin C, Searles R, Collins RH, DeAngelo DJ, Deininger MW, Dunn T, Hein T, Luskin MR, Medeiros BC, Oh ST, Pollyea DA, Steensma DP, Stone RM, Druker BJ, McWeeney SK, Maxson JE, Gotlib JR, Tyner JW.

Blood. 2019 Sep 12;134(11):867-879. doi: 10.1182/blood.2019000611. Epub 2019 Jul 31.

PMID:
31366621
5.

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.

Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J, Menghrajani K, Shaw C, Baer MR, Elliott MA, Perl AE, Ráčil Z, Mayer J, Zak P, Szotkowski T, de Botton S, Grimwade D, Mayer K, Walter RB, Krämer A, Burnett AK, Ho AD, Platzbecker U, Thiede C, Ehninger G, Stone RM, Röllig C, Tallman MS, Estey EH, Müller-Tidow C, Russell NH, Schlenk RF, Levis MJ.

Haematologica. 2020 Jan;105(1):161-169. doi: 10.3324/haematol.2018.208678. Epub 2019 Apr 19.

6.

Atomic and electronic reconstruction at the van der Waals interface in twisted bilayer graphene.

Yoo H, Engelke R, Carr S, Fang S, Zhang K, Cazeaux P, Sung SH, Hovden R, Tsen AW, Taniguchi T, Watanabe K, Yi GC, Kim M, Luskin M, Tadmor EB, Kaxiras E, Kim P.

Nat Mater. 2019 May;18(5):448-453. doi: 10.1038/s41563-019-0346-z. Epub 2019 Apr 15.

PMID:
30988451
7.

A Headache of a Diagnosis.

Stern RM, Luskin MR, Clark RP, Miller AL, Loscalzo J.

N Engl J Med. 2018 Aug 2;379(5):475-479. doi: 10.1056/NEJMcps1803584. No abstract available.

PMID:
30067932
8.

Chronic myeloid leukemia and pregnancy: patient and partner perspectives.

Luskin MR.

Expert Rev Hematol. 2018 Aug;11(8):597-599. doi: 10.1080/17474086.2018.1500889. Epub 2018 Jul 23. No abstract available.

PMID:
30012034
9.

Global signal of top-down control of terrestrial plant communities by herbivores.

Jia S, Wang X, Yuan Z, Lin F, Ye J, Hao Z, Luskin MS.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6237-6242. doi: 10.1073/pnas.1707984115. Epub 2018 May 30.

10.

How to treat chronic myeloid leukemia (CML) in older adults.

Luskin MR, DeAngelo DJ.

J Geriatr Oncol. 2018 Jul;9(4):291-295. doi: 10.1016/j.jgo.2018.01.008. Epub 2018 Feb 18. Review.

PMID:
29463446
11.

Publisher Correction: Sumatran tiger survival threatened by deforestation despite increasing densities in parks.

Luskin MS, Albert WR, Tobler MW.

Nat Commun. 2018 Feb 12;9(1):687. doi: 10.1038/s41467-018-03055-9.

12.

Targeting minimal residual disease: a path to cure?

Luskin MR, Murakami MA, Manalis SR, Weinstock DM.

Nat Rev Cancer. 2018 Apr;18(4):255-263. doi: 10.1038/nrc.2017.125. Epub 2018 Jan 29. Review.

13.

Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening.

Luskin MR, Discenza MN, Easter SR, Dal Cin P, Owen R, Ilagan B, Masiello M, Lane AA.

Blood Adv. 2017 Aug 15;1(19):1491-1494. doi: 10.1182/bloodadvances.2017008680. eCollection 2017 Aug 22.

14.

Management of older adults with myelodysplastic syndromes (MDS).

Luskin MR, Abel GA.

J Geriatr Oncol. 2018 Jul;9(4):302-307. doi: 10.1016/j.jgo.2017.12.002. Epub 2017 Dec 29. Review.

PMID:
29290596
15.

Cross-boundary subsidy cascades from oil palm degrade distant tropical forests.

Luskin MS, Brashares JS, Ickes K, Sun IF, Fletcher C, Wright SJ, Potts MD.

Nat Commun. 2017 Dec 20;8(1):2231. doi: 10.1038/s41467-017-01920-7.

16.

Sumatran tiger survival threatened by deforestation despite increasing densities in parks.

Luskin MS, Albert WR, Tobler MW.

Nat Commun. 2017 Dec 5;8(1):1783. doi: 10.1038/s41467-017-01656-4. Erratum in: Nat Commun. 2018 Feb 12;9(1):687.

17.

Late effects of blood and marrow transplantation.

Banerjee R, Luskin MR, Loren AW.

Haematologica. 2017 Nov;102(11):e465. doi: 10.3324/haematol.2017.176289. No abstract available.

18.

Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia.

Luskin MR, DeAngelo DJ.

Expert Rev Hematol. 2017 Dec;10(12):1033-1045. doi: 10.1080/17474086.2017.1397510. Epub 2017 Oct 30. Review.

PMID:
29069942
19.

Can Minimal Residual Disease Determination in Acute Myeloid Leukemia Be Used in Clinical Practice?

Luskin MR, Stone RM.

J Oncol Pract. 2017 Aug;13(8):471-480. doi: 10.1200/JOP.2017.021675. Review.

PMID:
28796964
20.

Microsphere-Based Assessment of DNA Methylation for AML Prognosis.

Wertheim GBW, Luskin MR, Carroll M, Master SR.

Methods Mol Biol. 2017;1633:125-136. doi: 10.1007/978-1-4939-7142-8_8.

PMID:
28735484
21.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A.

Blood. 2017 Aug 31;130(9):1156-1164. doi: 10.1182/blood-2017-03-772368. Epub 2017 Jul 3.

22.

Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice.

Luskin MR, DeAngelo DJ.

Curr Hematol Malig Rep. 2017 Aug;12(4):370-379. doi: 10.1007/s11899-017-0394-x. Review.

PMID:
28656487
23.

Curricular Time, Patient Exposure, and Comfort Caring for Lesbian, Gay, Bisexual, and Transgender Patients Among Recent Medical Graduates.

Honigberg MC, Eshel N, Luskin MR, Shaykevich S, Lipsitz SR, Katz JT.

LGBT Health. 2017 Jun;4(3):237-239. doi: 10.1089/lgbt.2017.0029. Epub 2017 Apr 18. No abstract available.

PMID:
28418736
24.

Self-reported sleep disturbance and survival in myelodysplastic syndromes.

Luskin MR, Cronin AM, Owens RL, DeAngelo DJ, Stone RM, Wadleigh M, Steensma DP, Abel GA.

Br J Haematol. 2017 May;177(4):562-566. doi: 10.1111/bjh.14573. Epub 2017 Mar 8.

PMID:
28272741
25.

The database of the PREDICTS (Projecting Responses of Ecological Diversity In Changing Terrestrial Systems) project.

Hudson LN, Newbold T, Contu S, Hill SL, Lysenko I, De Palma A, Phillips HR, Alhusseini TI, Bedford FE, Bennett DJ, Booth H, Burton VJ, Chng CW, Choimes A, Correia DL, Day J, Echeverría-Londoño S, Emerson SR, Gao D, Garon M, Harrison ML, Ingram DJ, Jung M, Kemp V, Kirkpatrick L, Martin CD, Pan Y, Pask-Hale GD, Pynegar EL, Robinson AN, Sanchez-Ortiz K, Senior RA, Simmons BI, White HJ, Zhang H, Aben J, Abrahamczyk S, Adum GB, Aguilar-Barquero V, Aizen MA, Albertos B, Alcala EL, Del Mar Alguacil M, Alignier A, Ancrenaz M, Andersen AN, Arbeláez-Cortés E, Armbrecht I, Arroyo-Rodríguez V, Aumann T, Axmacher JC, Azhar B, Azpiroz AB, Baeten L, Bakayoko A, Báldi A, Banks JE, Baral SK, Barlow J, Barratt BI, Barrico L, Bartolommei P, Barton DM, Basset Y, Batáry P, Bates AJ, Baur B, Bayne EM, Beja P, Benedick S, Berg Å, Bernard H, Berry NJ, Bhatt D, Bicknell JE, Bihn JH, Blake RJ, Bobo KS, Bóçon R, Boekhout T, Böhning-Gaese K, Bonham KJ, Borges PA, Borges SH, Boutin C, Bouyer J, Bragagnolo C, Brandt JS, Brearley FQ, Brito I, Bros V, Brunet J, Buczkowski G, Buddle CM, Bugter R, Buscardo E, Buse J, Cabra-García J, Cáceres NC, Cagle NL, Calviño-Cancela M, Cameron SA, Cancello EM, Caparrós R, Cardoso P, Carpenter D, Carrijo TF, Carvalho AL, Cassano CR, Castro H, Castro-Luna AA, Rolando CB, Cerezo A, Chapman KA, Chauvat M, Christensen M, Clarke FM, Cleary DF, Colombo G, Connop SP, Craig MD, Cruz-López L, Cunningham SA, D'Aniello B, D'Cruze N, da Silva PG, Dallimer M, Danquah E, Darvill B, Dauber J, Davis AL, Dawson J, de Sassi C, de Thoisy B, Deheuvels O, Dejean A, Devineau JL, Diekötter T, Dolia JV, Domínguez E, Dominguez-Haydar Y, Dorn S, Draper I, Dreber N, Dumont B, Dures SG, Dynesius M, Edenius L, Eggleton P, Eigenbrod F, Elek Z, Entling MH, Esler KJ, de Lima RF, Faruk A, Farwig N, Fayle TM, Felicioli A, Felton AM, Fensham RJ, Fernandez IC, Ferreira CC, Ficetola GF, Fiera C, Filgueiras BK, Fırıncıoğlu HK, Flaspohler D, Floren A, Fonte SJ, Fournier A, Fowler RE, Franzén M, Fraser LH, Fredriksson GM, Freire GB Jr, Frizzo TL, Fukuda D, Furlani D, Gaigher R, Ganzhorn JU, García KP, Garcia-R JC, Garden JG, Garilleti R, Ge BM, Gendreau-Berthiaume B, Gerard PJ, Gheler-Costa C, Gilbert B, Giordani P, Giordano S, Golodets C, Gomes LG, Gould RK, Goulson D, Gove AD, Granjon L, Grass I, Gray CL, Grogan J, Gu W, Guardiola M, Gunawardene NR, Gutierrez AG, Gutiérrez-Lamus DL, Haarmeyer DH, Hanley ME, Hanson T, Hashim NR, Hassan SN, Hatfield RG, Hawes JE, Hayward MW, Hébert C, Helden AJ, Henden JA, Henschel P, Hernández L, Herrera JP, Herrmann F, Herzog F, Higuera-Diaz D, Hilje B, Höfer H, Hoffmann A, Horgan FG, Hornung E, Horváth R, Hylander K, Isaacs-Cubides P, Ishida H, Ishitani M, Jacobs CT, Jaramillo VJ, Jauker B, Hernández FJ, Johnson MF, Jolli V, Jonsell M, Juliani SN, Jung TS, Kapoor V, Kappes H, Kati V, Katovai E, Kellner K, Kessler M, Kirby KR, Kittle AM, Knight ME, Knop E, Kohler F, Koivula M, Kolb A, Kone M, Kőrösi Á, Krauss J, Kumar A, Kumar R, Kurz DJ, Kutt AS, Lachat T, Lantschner V, Lara F, Lasky JR, Latta SC, Laurance WF, Lavelle P, Le Féon V, LeBuhn G, Légaré JP, Lehouck V, Lencinas MV, Lentini PE, Letcher SG, Li Q, Litchwark SA, Littlewood NA, Liu Y, Lo-Man-Hung N, López-Quintero CA, Louhaichi M, Lövei GL, Lucas-Borja ME, Luja VH, Luskin MS, MacSwiney G MC, Maeto K, Magura T, Mallari NA, Malone LA, Malonza PK, Malumbres-Olarte J, Mandujano S, Måren IE, Marin-Spiotta E, Marsh CJ, Marshall EJ, Martínez E, Martínez Pastur G, Moreno Mateos D, Mayfield MM, Mazimpaka V, McCarthy JL, McCarthy KP, McFrederick QS, McNamara S, Medina NG, Medina R, Mena JL, Mico E, Mikusinski G, Milder JC, Miller JR, Miranda-Esquivel DR, Moir ML, Morales CL, Muchane MN, Muchane M, Mudri-Stojnic S, Munira AN, Muoñz-Alonso A, Munyekenye BF, Naidoo R, Naithani A, Nakagawa M, Nakamura A, Nakashima Y, Naoe S, Nates-Parra G, Navarrete Gutierrez DA, Navarro-Iriarte L, Ndang'ang'a PK, Neuschulz EL, Ngai JT, Nicolas V, Nilsson SG, Noreika N, Norfolk O, Noriega JA, Norton DA, Nöske NM, Nowakowski AJ, Numa C, O'Dea N, O'Farrell PJ, Oduro W, Oertli S, Ofori-Boateng C, Oke CO, Oostra V, Osgathorpe LM, Otavo SE, Page NV, Paritsis J, Parra-H A, Parry L, Pe'er G, Pearman PB, Pelegrin N, Pélissier R, Peres CA, Peri PL, Persson AS, Petanidou T, Peters MK, Pethiyagoda RS, Phalan B, Philips TK, Pillsbury FC, Pincheira-Ulbrich J, Pineda E, Pino J, Pizarro-Araya J, Plumptre AJ, Poggio SL, Politi N, Pons P, Poveda K, Power EF, Presley SJ, Proença V, Quaranta M, Quintero C, Rader R, Ramesh BR, Ramirez-Pinilla MP, Ranganathan J, Rasmussen C, Redpath-Downing NA, Reid JL, Reis YT, Rey Benayas JM, Rey-Velasco JC, Reynolds C, Ribeiro DB, Richards MH, Richardson BA, Richardson MJ, Ríos RM, Robinson R, Robles CA, Römbke J, Romero-Duque LP, Rös M, Rosselli L, Rossiter SJ, Roth DS, Roulston TH, Rousseau L, Rubio AV, Ruel JC, Sadler JP, Sáfián S, Saldaña-Vázquez RA, Sam K, Samnegård U, Santana J, Santos X, Savage J, Schellhorn NA, Schilthuizen M, Schmiedel U, Schmitt CB, Schon NL, Schüepp C, Schumann K, Schweiger O, Scott DM, Scott KA, Sedlock JL, Seefeldt SS, Shahabuddin G, Shannon G, Sheil D, Sheldon FH, Shochat E, Siebert SJ, Silva FA, Simonetti JA, Slade EM, Smith J, Smith-Pardo AH, Sodhi NS, Somarriba EJ, Sosa RA, Soto Quiroga G, St-Laurent MH, Starzomski BM, Stefanescu C, Steffan-Dewenter I, Stouffer PC, Stout JC, Strauch AM, Struebig MJ, Su Z, Suarez-Rubio M, Sugiura S, Summerville KS, Sung YH, Sutrisno H, Svenning JC, Teder T, Threlfall CG, Tiitsaar A, Todd JH, Tonietto RK, Torre I, Tóthmérész B, Tscharntke T, Turner EC, Tylianakis JM, Uehara-Prado M, Urbina-Cardona N, Vallan D, Vanbergen AJ, Vasconcelos HL, Vassilev K, Verboven HA, Verdasca MJ, Verdú JR, Vergara CH, Vergara PM, Verhulst J, Virgilio M, Vu LV, Waite EM, Walker TR, Wang HF, Wang Y, Watling JI, Weller B, Wells K, Westphal C, Wiafe ED, Williams CD, Willig MR, Woinarski JC, Wolf JH, Wolters V, Woodcock BA, Wu J, Wunderle JM Jr, Yamaura Y, Yoshikura S, Yu DW, Zaitsev AS, Zeidler J, Zou F, Collen B, Ewers RM, Mace GM, Purves DW, Scharlemann JP, Purvis A.

Ecol Evol. 2016 Dec 16;7(1):145-188. doi: 10.1002/ece3.2579. eCollection 2017 Jan.

26.

Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML.

Dinardo CD, Luskin MR, Carroll M, Smith C, Harrison J, Pierce S, Kornblau S, Konopleva M, Kadia T, Kantarjian H, Wertheim GB, Master SR.

Am J Hematol. 2017 Feb;92(2):E14-E15. doi: 10.1002/ajh.24597. No abstract available.

27.

Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.

Luskin MR, Carroll M, Lieberman D, Morrissette JJD, Zhao J, Crisalli L, Roth DB, Luger SM, Porter DL, Reshef R.

Biol Blood Marrow Transplant. 2016 Nov;22(11):1961-1967. doi: 10.1016/j.bbmt.2016.07.018. Epub 2016 Jul 28.

28.

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.

Luskin MR, Gimotty PA, Smith C, Loren AW, Figueroa ME, Harrison J, Sun Z, Tallman MS, Paietta EM, Litzow MR, Melnick AM, Levine RL, Fernandez HF, Luger SM, Carroll M, Master SR, Wertheim GB.

JCI Insight. 2016 Jun 16;1(9). pii: e87323.

29.

Impacts of hunting on tropical forests in Southeast Asia.

Harrison RD, Sreekar R, Brodie JF, Brook S, Luskin M, O'Kelly H, Rao M, Scheffers B, Velho N.

Conserv Biol. 2016 Oct;30(5):972-81. doi: 10.1111/cobi.12785. Epub 2016 Aug 20. Review.

PMID:
27341537
30.

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.

Sloan CE, Luskin MR, Boccuti AM, Sehgal AR, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Gimotty PA, Carroll M.

PLoS One. 2016 Apr 6;11(4):e0153016. doi: 10.1371/journal.pone.0153016. eCollection 2016.

31.

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.

Luskin MR, Lee JW, Fernandez HF, Abdel-Wahab O, Bennett JM, Ketterling RP, Lazarus HM, Levine RL, Litzow MR, Paietta EM, Patel JP, Racevskis J, Rowe JM, Tallman MS, Sun Z, Luger SM.

Blood. 2016 Mar 24;127(12):1551-8. doi: 10.1182/blood-2015-07-657403. Epub 2016 Jan 11.

32.

Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm.

Aikawa V, Porter D, Luskin MR, Bagg A, Morrissette JJ.

Cancer Genet. 2015 Dec;208(12):625-9. doi: 10.1016/j.cancergen.2015.10.003. Epub 2015 Nov 3.

PMID:
26628205
33.

Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.

Luskin MR, Ganetsky A, Landsburg DJ, Loren AW, Porter DL, Nasta SD, Svoboda J, Luger SM, Frey NV.

Br J Haematol. 2016 Jul;174(2):332-4. doi: 10.1111/bjh.13771. Epub 2015 Sep 25. No abstract available.

PMID:
26403537
34.

A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.

Luskin MR, Banerjee R, Del Percio S, Loren AW.

Curr Hematol Malig Rep. 2015 Sep;10(3):225-36. doi: 10.1007/s11899-015-0274-1. Review.

PMID:
26162948
35.

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Luskin MR, Huen AO, Brooks SA, Stewart C, Watt CD, Morrissette JJ, Lieberman DB, Bagg A, Rosenbach M, Perl AE.

Haematologica. 2015 Oct;100(10):e412-4. doi: 10.3324/haematol.2015.129346. Epub 2015 Jun 25. No abstract available.

36.

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.

Reshef R, Huffman AP, Gao A, Luskin MR, Frey NV, Gill SI, Hexner EO, Kambayashi T, Loren AW, Luger SM, Mangan JK, Nasta SD, Richman LP, Sell M, Stadtmauer EA, Vonderheide RH, Mick R, Porter DL.

J Clin Oncol. 2015 Jul 20;33(21):2392-8. doi: 10.1200/JCO.2014.60.1203. Epub 2015 Jun 8.

37.

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R.

Am J Transplant. 2015 Oct;15(10):2665-73. doi: 10.1111/ajt.13324. Epub 2015 May 18.

38.

Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP.

Wertheim GB, Smith C, Luskin M, Rager A, Figueroa ME, Carroll M, Master SR.

Clin Chem. 2015 Jan;61(1):249-58. doi: 10.1373/clinchem.2014.229781. Epub 2014 Oct 27.

39.

A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types.

Tsai DE, Luskin MR, Kremer BE, Chung AK, Arnoldi S, Paralkar VR, Nasta SD, Stadtmauer EA, Schuster SJ, Xavier M.

Leuk Lymphoma. 2015 May;56(5):1530-2. doi: 10.3109/10428194.2014.963577. Epub 2014 Nov 5. No abstract available.

PMID:
25219594
40.

R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.

Frosch Z, Luskin MR, Landsburg DJ, Schuster SJ, Svoboda J, Loren AW, Porter DL, Stadtmauer EA, Nasta SD.

Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):92-7. doi: 10.1016/j.clml.2014.07.017. Epub 2014 Aug 1.

PMID:
25174772
41.

Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimen.

Luskin MR, Roy DB, Wasik MA, Loren AW.

Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):e55-8. doi: 10.1016/j.clml.2013.11.010. Epub 2013 Nov 22. No abstract available.

PMID:
24393621
42.

CLL/SLL diagnosed in an adolescent.

Luskin M, Wertheim G, Morrissette J, Daber R, Biegel J, Wilmoth D, Kersun L, King R, Paessler M, Simon C, Aplenc R, Loren A.

Pediatr Blood Cancer. 2014 Jun;61(6):1107-10. doi: 10.1002/pbc.24884. Epub 2013 Nov 26.

PMID:
24281971
43.

More of the same? Treatment in mental health courts.

Luskin ML.

Law Hum Behav. 2013 Aug;37(4):255-66. doi: 10.1037/lhb0000016. Epub 2012 Dec 3.

PMID:
23205570
44.

Management of relapsed and relapsed/refractory multiple myeloma.

Laubach JP, Mitsiades CS, Mahindra A, Luskin MR, Rosenblatt J, Ghobrial IM, Schlossman RL, Avigan D, Raje N, Munshi NC, Anderson KC, Richardson PG.

J Natl Compr Canc Netw. 2011 Oct;9(10):1209-16.

PMID:
21975917
45.

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.

Reshef R, Luskin MR, Kamoun M, Vardhanabhuti S, Tomaszewski JE, Stadtmauer EA, Porter DL, Heitjan DF, Tsai de E.

Am J Transplant. 2011 Apr;11(4):817-25. doi: 10.1111/j.1600-6143.2011.03454.x. Epub 2011 Mar 14.

46.

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

Reshef R, Vardhanabhuti S, Luskin MR, Heitjan DF, Hadjiliadis D, Goral S, Krok KL, Goldberg LR, Porter DL, Stadtmauer EA, Tsai DE.

Am J Transplant. 2011 Feb;11(2):336-47. doi: 10.1111/j.1600-6143.2010.03387.x. Epub 2011 Jan 10.

47.

p27(KIP1) regulates neurogenesis in the rostral migratory stream and olfactory bulb of the postnatal mouse.

Li X, Tang X, Jablonska B, Aguirre A, Gallo V, Luskin MB.

J Neurosci. 2009 Mar 4;29(9):2902-14. doi: 10.1523/JNEUROSCI.4051-08.2009.

48.

Gene transfer to the rodent embryo by retroviral vectors.

Luskin MB.

Methods Mol Biol. 2008;461:201-20. doi: 10.1007/978-1-60327-483-8_13. Review. No abstract available.

PMID:
19030798
49.

Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.

Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT Jr, Kottilil S, Lifson JD, Metcalf JA, Lempicki RA, Connors M.

J Virol. 2008 Apr;82(8):3997-4006. doi: 10.1128/JVI.01545-07. Epub 2008 Feb 6.

50.

Subventricular zone neuronal progenitors undergo multiple divisions and retract their processes prior to each cytokinesis.

Coskun V, Falls DL, Lane R, Czirok A, Luskin MB.

Eur J Neurosci. 2007 Aug;26(3):593-604. Epub 2007 Jul 25.

Supplemental Content

Loading ...
Support Center